Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Allogeneic Hematopoietic Cell Transplantation: early-phase trial registry

2 of 3 indexed Allogeneic Hematopoietic Cell Transplantation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Allogeneic Hematopoietic Cell Transplantation: 3 US clinical trials tracked, 2 recruiting.

Allogeneic Hematopoietic Cell Transplantation is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Masonic Cancer Center, University of Minnesota, running 1 of these trials.

Enrollment posture brief

Registry condition allogeneic-hematopoietic-cell-transplantation

OPEN 2 | RECR 67% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Allogeneic Hematopoietic (th…67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Allogeneic Hematopoietic Cell Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Allogeneic Hematopoietic Cell Transplantation is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Allogeneic Hematopoietic Cell Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Serum ferritin Procedure
1 trials
magnetic resonance imaging Procedure
1 trials
Nicotinamide riboside (NR) Drug
1 trials
Alemtuzumab Drug
1 trials

US sites by state

Facility locations filed on Allogeneic Hematopoietic Cell Transplantation trials. A trial with sites in several states counts in each.

Ohio 2 trials
Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Allogeneic Hematopoietic Cell Transplantation page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allogeneic Hematopoietic Cell Transplantation condition card totals 3 registered trials; most-linked intervention Serum ferritin; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.